Apolipoproteins Quantified Using Blood Volumetric Absorptive Microsampling and High-Throughput Mass Spectrometry for Risk Assessment in Ischemic Heart Disease
- 19 March 2024
- journal article
- letter
- Published by Wolters Kluwer Health in Circulation
- Vol. 149 (12) , 970-972
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- Feasibility of Patient-Centric Remote Dried Blood Sampling: The Prediction, Risk, and Evaluation of Major Adverse Cardiac Events (PRE-MACE) StudyBiodemography and Social Biology, 2020
- Biometric and Psychometric Remote Monitoring and Cardiovascular Risk Biomarkers in Ischemic Heart DiseaseJournal of the American Heart Association, 2020
- Quality Control and Outlier Detection of Targeted Mass Spectrometry Data from Multiplex Protein PanelsJournal of Proteome Research, 2020
- Application of volumetric absorptive microsampling for robust, high-throughput mass spectrometric quantification of circulating protein biomarkersClinical Mass Spectrometry, 2017
- Very-Low-Density Lipoprotein–Associated Apolipoproteins Predict Cardiovascular Events and Are Lowered by Inhibition of APOC-IIIJACC, 2017